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Purpose: To determine the long-term outcome and prognostic factors after early infrain- 
guinal graft failure (<30 days). 
Metbods: Retrospective analysis of limb salvage data, patency data, and prognostic risk 
factors in 112 new infrainguinal bypass grafts from 1985 to 1995 that occluded within 
30 days of operation. 
Result: Thirty-six femoropopliteal and 76 femorotibial/femoropedal arterial bypass 
("index') procedures were performed for rest pain (50%), tissue loss (31%), or disabling 
claudication (19%). In 103 patients, an immediate additional revascularization ("take- 
back") procedure was performed at the time of early graft failure. Life table analysis of 
the takeback procedures for threatened limbs (n = 84) revealed limb salvage rates of 74%, 
54%, 40%, and 31% at 1 month, 1 year, 3 years, and 5 years, respectively. The 1-month 
limb salvage rate (threatened limbs) was 12% (1 of 8) in patients who were not taken back 
for revascularization a d 33% (4 of 12) in patients who had undergone more than one 
takeback procedure within 30 days. The secondary graft patency rates for the takeback 
procedures (n = 103) were 70%, 37%, 27%, and 23% at 1 month, 1 year, 3 years, and 5 
years, respectively. Univariate and life table analysis revealed that patients who were given 
antieoagulation medication after the index procedure (before graft thrombosis) or 
patients who had undergone previous ipsilateral leg revascularization had significantly 
lower rates of limb salvage and graft patency (p < 0.05). The limb salvage rate was also 
significantly worse in patients who had single-vessel rtmoff compared with those who had 
multiple-vessel runoff (p < 0.01). Thrombectomy and revision or eomplete graft replace- 
ment had a bettet secondary patency rate than thrombectomy alone (p < 0.05). Autoge- 
nous rein grafts had bet-ter outcome than polytetrafluoroethylene-containing grafts, but 
statistical significance was not achieved. No significant differences in limb salvage or graft 
patency rates were found between femoropopliteal versus femorotibial/femoropedal 
bypass grafting, age, gender, previous inflow surgery, diabetes, hypertension, smoking, 
or cardiac, renal, or pulmonary disease. 
Condusion: The long-term limb salvage and graft patency rates after takeback revasctdar- 
ization procedures for early graft failure are poor. Despite poor outcome, a single 
takeback procedure appears warranted in all patients. Mtfltiple takeback procedures, 
however, do not appear to be justified, especially in patients who are given anticoagula- 
tion medication after the index bypass procedure, repeat leg bypass procedures, or if there 
is no potential for graft revision. (J Vasc Surg 1997;26:425-38.) 
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Contemporary reports of  exccllent limb salvagc 
rates, low morbidity rates, and prolonged graft pa- 
tency rates after infrainguinal arterial bypass proce- 
dures 1-3 and recognition of poor functional outcome, 
diminished quality of life, and loss of independence 
after lower extremity amputation 1,4,s have led to an 
increasingly aggressive surgical approach to limb sal- 
vage in patients who have severe lower extremity 
ischemia. Inevitably, increasing numbers of patients 
with recurrent limb ischemia re undergoing further 
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Table I. Procedure and grafts used at initial 
(index) bypass urgery (n = 112) 
No. (%) 
Bypass location 
Femoral to popliteal 36 (32) 
Above-knee 9 (8) 
Below-knee 27 (24) 
Femoral to tibial/pedal 76 (68) 
Femoral-tibial/peroneal 6i (54) 
Femoral-pedal 10 (9) 
Popliteral-tibial/pedal 5 (4) 
Graft material 
Autogenous vein 76 (68) 
In sim saphenous vein 42 (38) 
Reversed GSV 17 (15) 
Composite rein 17 (15) 
PTFE 32 (29) 
PTFE only 10 (9) 
Composit¢ PTFE & vein 22 (20) 
Homograft 4 (4) 
GSV, Greater saphenous vein. 
attempts at revascularization after failure of one or 
more previous ipsilateral bypass grafts. Poor results in 
some earlier series have led respected surgcons to 
suggest hat primary amputation may be a better 
option than further attempts at limb salvage, 6 espe- 
cially when autogenous vein is unavailable.~,7 More 
recent series from multiple centers, however, have 
shown satisfactory long-term outcome after second- 
am/or tertiary bypass procedures performed for limb 
salvage that supports an aggressive approach to revas- 
cularization. TM These reports have focused on late 
graft failures (>30 days), which occur in 20% to 50% 
of cases with extended follow-up 2,12 and are usually 
caused by progression of disease, fibrointimal hyper- 
plasia, or other intrinsic defects. 13,1s,16 
Long-term outcome after aggressive attempts at 
revascularization f early graft failures (<30 days) is 
less clear. The incidence of early graft failure varies 
from 2% to 25% depcnding on the serics and the type 
ofconduit. 3,9,11,13,17-21 Underreporting occurs when 
grafts that fail but are revised in the immediate post- 
operative period are incorrectly considered to have 
primary patency. 22 Technical error, poor runoff, 
hemodynamic derangements, inadequate conduit 
(judgement errors), or hypercoagulopathy arecom- 
monly cited reasons for early graft failures, 9,13,19 al- 
though no reason for thrombosis i identified in as 
many as 33% ofcases. 9 
Whereas as many as 20% ofpatients w, ith late graft 
failures who originally undergo peration for threat- 
ened limbs may not need further evascularization to 
maintain limb salvage, 9 17 early graft failure in threat- 
ened limbs generally leads to amputation without 
additional revascularization attempts. The optimum 
management for patients who receive an apparent 
technically adequate bypass graft that nevertheless 
develops graft thrombosis in the early postoperative 
period remains unclear. It is ditficult to recommend 
amputation without exhansting all chances to attain 
limb salvage; however, aggressive but unsuccessful 
attempts at revascularization that ultimately result in 
limb loss and expose the patient o additional opera- 
tive risk and cost are equally unrewarding. 
The purpose of this study was to retrospectively 
review our experience with early infrainguinal graft 
failures occurring over a 10-year period to define the 
long-term sequelae and to identify factors that might 
predict he ultimate outcome of the extremity. 
PATIENTS AND METHODS 
Operative logs covering January 1985 through 
October 1995 were reviewed, and patients who 
underwent infrainguinal lower extremity bypass pro- 
cedures were identified. Medical records were ana- 
lyzed, and data on patients who underwent place- 
ment of new grafts that occluded within 30 days of 
operation were collected. Patients whose grafts were 
found to be failing but not thrombosed and who 
underwent repair were excluded from the study. 
Only patients who had thrombosis of newly placed 
bypass grafts were considered. 
One hundred twelve early graft failures in 102 
patients (some patients experienced early failure of 
new grafts in contralateral or ipsilateral limbs remote 
from their first event) were identified. Approximately 
1600 infrainguinal bypass procedures were per- 
formed during the study period. There were 73 men 
(65%) and 39 women (35%), with a mean age ofó5 
-+ 11 years. Comorbid risk factors were smoldng 
(66%), hypertension (60%), cardiac disease (43%), 
diabetes (33%), pulmonary disease (24%), hyperlipid- 
emia (21%), and lddney disease (9%). The indications 
for surgery were ischemic rest pain in 49 patients 
(44%; ABI, 0.30 + 0.18), tissue loss in 35 (31%; 
ABI, 0.36 + 0.13), severe lifestyle-limiting claudica- 
tion in 21 (19%; ABI, 0.45 _+ 0.17), and acute 
ischemia with limb threat (rest pain) in seven (6%; 
ABI, 0.04 _+ 0.09). Table I shows the initial (index) 
procedure performed and the grafts used. 
In 48 cases (43%), the index procedure was a 
repeat leg bypass. Thirty-one had undergone a single 
previous ipsihteral leg bypass procedure, whereas 17 
had undergone two or more previous bypass proce- 
dures. The most recent procedure was a femoropop- 
liteal bypass procedure in 67% and a femorotibial/ 
femoroperoneal bypass procedure in 33%. Of the 
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repeat leg bypass procedures, autogenous vein had 
been previously used in 58% and not used in 34% 
(polytetrafluoroethylene [PTFE] only) of the cases. 
Information was not available in the remaining 8% to 
determine the previous graft used. 
Runoff, dcfined as the number ofvessels in conti- 
nuity to the anlde from the distal anastomosis, was to 
a singlc vessel in 82%, two vessels in 9%, and three 
vesscls in 9%. There was no history of proximal in- 
flow surgery in 77 of the patients (68%), whereas 
there was history of prior aortobifemoral or aortobi- 
iliac bypass in 1 ó (14%), femorofemoral rtery bypass 
in 10 (9%), axillobifemoral bypass in five (5%), and 
previous iliac percutaneous transluminal angioplas- 
ties with steht placement in two of the patients (2%). 
An immediate, additional revascularization 
("takeback") procedure after early graft thrombosis 
was performed in 103 cases. Thrombectomy alone 
was performed on 44 grafts (43%), thrombectomy 
and revision on 43 grafts (42%), and placement of a 
completely new graft in 14 patients (13%). 
Systemic anticoagulation with heparin was used 
after the index bypass procedure (before early graft 
thrombosis) in 43 procedures (38%). Conversion to 
warfarin was made in seven patients before early graft 
failure. All patients »vere anticoagulated after the 
takeback procedure. 
Long-term data wert collected until one of two 
endpoints in the study was reached: limb loss, de- 
fined as amputation above the transmetatarsal level, 
or death. Definitions ofpatency, limb salvage, sever- 
ity of ischemia, and risk factors are in accordance 
with the suggested standards for reports dealing with 
lower extremity ischemia. 2a 
To identify prognostic risk factors of limb sal- 
vage, patients with threatened limbs who underwent 
a takeback procedure were grouped into those who 
achieved limb salvage (n = 40) or had an amputation 
(n = 39) at 1 year. Cross-tabulation with X 2 was used 
for comparing specific variables between outcome 
groups. Statistical significance was considered for p 
values less than 0.05. 
Graft patency and limb salvage data were ana- 
lyzed using the ICaplan-Meier life table method. Fol- 
low-up time was counted from the index bypass 
procedure. Statistical testing between life table 
curves were done using the Mantel-Haenszel test, 
with significance considered for p values less than 
0.05. 
RESULTS 
Of the 112 early graft failures, the majority oc- 
curred within the first 24 hours after surgery (Fig. 1). 
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Fig. 1. Postoperative day of graft failure. 
One hundred three underwent an immediate take- 
back procedurc; whereas nine lower extremities had 
no further attempts at revascularization. Of these 
nine procedures, eight were performed for limb sal- 
vage, with seven (88%) undcrgoing amputation 
within the next 1 month. These cases were not in- 
cluded for further life table or univariate analysis. 
Life table analysis of the 103 takeback procedures 
revealed that patients with claudication had signifi- 
cantly bettet limb salvage rates than those who had 
undergone the procedures for rest pain or tissue loss 
(Fig. 2). Patients with claudication wcre excluded 
from all further analysis for lirnb salvage. Cumulative 
limb salvage data for the 84 threatened limbs are 
shown in Fig. 3 and Table II. 
Univariate analysis between thrcatcned limbs that 
achieved limb salvage (n = 40) compared with am- 
putation (n = 39) at 1 year revcaled that the ampu- 
tated group had a significantly higher proportion 
of anticoagulation after the index procedure (before 
graft thrombosis; p < 0.001), repeat leg bypass 
procedures (p < 0.05), and runoff of only one vessel 
(p > 0.01). A borderline significant increase (p < 
0.10) was seen with hypertension, PTFE-containing 
grafts (compared with autogenous vein grafts), and 
femorotibial/femoropedal bypass grafts (compared 
with femoropopliteal bypass grafts). No significant- 
difference (p > 0.10) was found with previous inflow 
procedures, age, gender, diabetes, smoldng, cardiac 
disease, renal disease, or pulmonary disease. 
Life table analysis for limb salvage confirmed that 
patients who had anticoagulation medication after 
the index bypass procedure (before graft thrombosis) 
and repeat leg bypass procedures had significantly 
lower rates oflimb salvage (Figs. 4 and 5). Of the 84 
takeback procedures performed for threatened limbs, 
there were 23 performed on patients who had had 
anticoagulation medication after a repeat leg bypass 
procedure (index procedure). In these cases, the limb 
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Fig. 2. Cumulative limb salvage rate by surgical indication for takeback procedures after early 
graft failure. 
100% 
80% 
60% 
>= 40% 
E 20% 
( J  
0% 
[ All Takebacks with Threatened L imbs (n=84)] 
| 
I I I I I [ [ 
0 12 24 36 48 60 72 84 96 
Months 
Fig. 3. Cumulative limb salvage rate (threatened limbs) for takeback procedures after early 
graft failure. 
salvage rate was 57% and 30% at 1 and ö months, 
respectively. 
Ahhough autogenous veins grafts had bettet limb 
salvage rates than PTFE-containing rafts, statistical 
significance was not achieved (Fig. 6). No significant 
difference was seen between femoropopliteal nd 
femorodistal bypass grafts (data not shown). 
Limb salvage at 1 year was achieved in 11 out of 
12 threatened limbs (92%) with runoff of two or 
three vessels compared with 46% of 72 threatened 
limbs with single-vessel runoff (p < 0.01). 
Seventeen of the 103 takeback patients had at 
least one additional takeback procedure performed 
(i.e., at least two total) within the next 30 days for 
another event of early graft thrombosis. The 
1-month limb salvage rate in this subsct of multiple 
takeback cases was 33% (four of 12). In comparison, 
the 1-month limb salvage rate was 74% (63 of 84) for 
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Fig. 4. Cumulative limb salvage rate (threatened limbs) after takeback procedures for early 
graft failure: comparison ofpatients anticoagulated and those not anticoagulated after the index 
procedure (before thrombosis). 
Table II. Cumulative limb salvage data (threatened limbs) for takeback procedures after early 
graft failure 
Interval No. of limbs No. of /imbs No. of limbs Interval limb Interval limb Cumulative limb Standard 
(mo) at risk amputated withdrawn amputation rate (%) salvage rate (%) salvage rate (%) error (%) 
0-1 84 21 4 26% 74% 74% 4% 
1-3 59 7 2 12% 88% 65% 5% 
3-6 50 5 1 10% 90% 58% 5% 
6-9 44 1 1 2% 98% 57% 6% 
9-12 42 2 3 5% 95% 54% 6% 
12-18 37 2 4 6% 94% 51% 6% 
18-24 31 1 3 4% 96% 49% 6% 
24-36 27 4 4 17% 83% 40% 6% 
36-48 19 2 5 14% 86% 35% 6% 
48-60 12 1 1 9% 91% 31% 8% 
60-72 10 0 3 0% 100% 31% 8% 
72-84 7 1 3 25% 75% 24% 8% 
84-96 3 0 2 0% 100% 24% 12% 
96-108 1 0 0 0% 100% 24% 21% 
108-120 1 0 0 0% 100% 24% 21% 
all takebacks and 12% (one of eight) for cases not 
taken back for additional revascularization. Although 
the 1-month limb salvage rate was significantly better 
for all takebacks compared with not taldng the pa- 
tient back for revascularization (p < 0.01), there was 
no statistically significant difference between multiple 
takebacks and not taldng the patient back for revas- 
cularization (p )  0.10). 
The cumulative secondary patency rate for all 
takeback procedures i  shown in Fig. 7 and Table III. 
Analysis includes 89 index bypass grafts that were 
salvaged with thrombectomy with or without revi- 
sion and 14 new grafts that were placed at the take- 
back procedure. Unlike limb salvage, there was no 
significant difference in graft patency rates between 
patients with claudication or those with threatened 
limbs (data not shown), therefore patients with clau- 
dication were included in all life table analyses for 
graft patency. 
Patency rates after thrombectomy alone were sig- 
nificantly worse than patency rates after thrombec- 
tomy with revision or placement ofa completely new 
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Fig. 5. Cumulative limb salvage rate (threatened limbs) after takeback procedures for early 
graft failure: comparison ofprimary and repeat leg bypass grafts. 
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Fig. 6. Cumulative limb salvage rate (threatened limbs) after takeback procedures for early 
graft fäilure: comparison of autogenous vein and PTFE-containing rafts. 
graft at the takeback operation (p < 0.05; Fig. 8). 
Although the limb salvage rate was also worse when 
only a thrombectomy was performed, this difference 
dicl not achieve statistical significance (data not 
shown). Patients who were given anticoagulation 
medication after the index bypass procedure (before 
early graft failure) or who undcrwent a rcpeat leg 
bypass procedure had a significantly worse graft pa- 
tency rate after takeback operations (Figs. 9 and 10). 
Autogenous vein grafts had a better patency rate than 
PTFE-containing grafts, but this difference did not 
achieve statistical significance (Fig. 11). No differ- 
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Fig. 7. Cumulative secondary patency rate for takeback procedures after early graft failure. 
Table I I I .  Cumulative secondary patency data for takeback procedures after early graft failure 
Interval No. of grafts No. of grafts No. of grafts Interval graft Interval graft Cumulative secondary 
(mo) at risk failed withdrawn failure rate (%) patency rate (%) patency rate (%) Standard error (%) 
0-1 103 31 2 30% 2% 70% 4% 
1-3 70 18 1 26% 1% 52% 4% 
3-6 51 9 3 18% ö% 43% 5% 
6-9 39 4 1 10% 3% 38% 5% 
9-12 34 1 2 3% 6% 37% 5% 
12-18 31 3 1 10% 3% 34% 5% 
18-24 27 .3 2 11% 7% 30% 5% 
24-36 22 2 4 9% 18% 27% 5% 
36-48 16 0 2 0% 13% 27% 6% 
48-60 14 2 4 14% 29% 23% 5% 
60-72 8 1 2 13% 25% 20% 6% 
72-84 5 0 1 0% 20% 20% 8% 
ence in patency rate was found between femoropop- 
liteal and femorotibial/femoropedal bypass grafts 
(data not shown). 
Univariate analysis of risk factors between pa- 
tients who were given anticoagulation medication 
after the index procedure (before early graft failure) 
and those who were not, and between primary and 
repeat leg bypass procedures, are shown in Table IV. 
Table V shows the postoperative complications 
associated with the 103 takeback procedures for early 
graft failure. Fifty-one percent of the cases had a 
complication, with the majority being wound-re- 
lated. Wound infections resulted in incisional dehis- 
cence in 41 cases (40%). In six of these cases, the 
graft subsequently became infected, resulting in early 
amputation (<2 months) in four out 0ffive threat- 
ened limbs. Significant wound hematomas required 
operative drainage in 20%. There was only one peri- 
operative death. 
D ISCUSS lON 
Craver and associates 24in 1973 reported on the 
outcome of femoropopliteal bypass grafts after early 
graft failure (<30 days) and found that 23% ofthose 
patients underwent an amputation as their next pro- 
cedure. Brewster et al. 17 reported similar findings 
after late failures of femoropopliteal bypass grafts; 
25% of those patients underwent an amputation as 
the hext procedure. In contrast, the decision to per- 
form an amputation as the very hext procedure was 
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Fig. 9. Cumulative secondary patency rate after takeback procedures for early graft failure: 
comparison of patients who were given anticoagulation medication and those not given 
anticoagulation medication after the index procedure (before thrombosis). 
made in only 6% of cases in this series of early graft 
failures. This was despite the fact that more than 90% 
of index procedures were infrageniculate bypass pro- 
cedures. In 94% of the cases, the patient was taken 
back to surgery, and an additional attempt at revas- 
cularization was performed. This underscores the 
recent trends in more aggressive attempts at limb 
salvage. Despite immediate takeback revasculariza- 
tion, 26% of patients with threatened limbs in this 
series required an amputation within 1 month. The 
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Fig. 10. Cumulative secondary patency rate after takeback procedures for early graft failure: 
comparison of primary and repeat leg bypass grafts. 
long-term results were not much better, with 1-year 
limb salvage and secondary graft patency rates of 59% 
and 18%, respectively (Figs. 3 and 7, Tables II and 
III). Although most patients benefit from the tal~e- 
back procedure, the poor results would suggest hat 
a more selective approach may be appropriate. 
The limb salvage and graft patency results after 
early graft failure in this series are markedly inferior 
to published results after late graft failure from sev- 
eral large series. 8,1°,11,14 Belkin et al.,12 when looking 
at a subgroup of 44 grafts that failed within 3 months 
and underwent repeat revascularization, found a 27% 
primary patency rate, a 30% secondary patency rate, 
and a 44% limb salvage rate 4 years after the repeat 
procedure. This was significantly worse than the 52% 
primary patency rate, 61% secondary patency rate, 
and 75% limb salvage rate in the 169 repeat bypass 
procedures performed because grafts had failed after 
3 months. Their long-term results after revasculariza- 
tion of grafts that failed within 3 months were simi- 
lar, but still better than the results found from this 
study in grafts that failed within 30 days. Clearly, 
patients with early graft failures present a formidable 
treatment challenge. 
One of the goals of this study was to identify risk 
factors specifically available for consideration at the 
time of early graft failure that could predict the ulti- 
mate fate of the limb and therefore influence the 
decision to take the patient back for revasculariza- 
tion. Not surprisingly, patients with claudication had 
a significantly higher rate of limb salvage compared 
with patients who had rest pain or tissue loss (Fig. 2). 
Interestingly, although secondary patency rates have 
been reported superior for patients with claudication 
over those with threatened limbs, 12 no significant 
difference was identified in this series, for reasons that 
are not entirely certain. 
Looking at other variables, the most striking 
findings were the prognostic value of the presence 
or absence of anticoagulation medication after the 
index procedure (before early thrombosis) and 
whether the index procedure was a primary or a 
repeat leg bypass procedure. 
Although all patients were given anticoagulation 
medication after the takeback procedure, there was 
an impressive negative association between anticoag- 
ulation medication after the index procedure and 
limb loss along with graft patency (Figs. 4 and 9). 
This result does not likely represent a harmful effect 
of heparin or warfarin, but instead reflects the ex- 
tremely poor outcome if thrombosis occurs in the 
presence of anticoagulation medication. Patients 
who receive anticoagulation medication after the in- 
dex procedure were probably judged to be at in- 
creased risk of failure, as evident by the higher pro- 
portion of PTFE-containing grafts, cardiac disease, 
and repeat leg bypass procedures (Table IV). Al- 
though this study does not address the indication or 
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Fig. 11. Cumulative secondary patency rate after takeback procedures for early graft failure: 
comparison of autogenous rein and PTFE-containing rafts. 
role of anticoagulation after new bypass grafts, it 
does show that early thrombosis in patients who are 
already taking anticoagulation medication predicts a 
bad outcome. 
Poor limb salvage and graft patency results after 
takeback of repeat leg bypass procedures compared 
with primary procedures was another major finding 
identified in this study. Patients who required a re- 
peat leg bypass procedure have already failed previ- 
ous revascularization(s) and have declared them- 
selves a more difficult population to treat. They are 
more likely to have severe atherosclerosis, hyperco- 
agulopathy, and poor-quality autogenous veins, each 
of which would increase the likelihood of carly graft 
failure. In this series, patients who required a repeat 
leg bypass procedure had a significantly higher pro- 
portion of diabetes, hypertension, cardiac disease, 
history of previous inflow procedure, femorotibial/ 
femoropedal bypass procedures (compared with fem- 
oropopliteal), and PTFE-containing grafts (com- 
pared with autogenous vein; Table IV). Surprisingly, 
these comorbid risk factors did not individually im- 
pact on limb salvage or graft patency rates after early 
graft failure. 
Patients with more than one vessel runoff had a 
significantly better limb salvage rate at 1 year (92%) 
compared with those with single-vessel runoff (46%). 
This would suggest that aggressive attempts at revas- 
cularization should be made in all cases of early graft 
failure with more than one-vessel runoff. Unfortu- 
nately, as more than 80% of all bypass grafts and 
nearly all the femorotibial/femoropedal bypass grafts 
in this series had only single-vessel runoff, the useful- 
ness of runoff alone to predict outcome is limited. 
Other reports have found poor correlation between 
run offscores and outcomc.  25-27 
Limb salvage and graft patency rates were better 
in autogenous rein grafts compared with PTFE-con- 
taining grafts (Figs. 6 and 11). Statistical signifi- 
cance, however, was not achieved, in part because of 
the smaller number ofPTFE-containing rafts in this 
series. Our policy has been to use an all-autogenous 
vein graft whenever possible. Numerous reports have 
shown the superiority of autogenous vein over PTFE 
grafts .  2'10-14,17,27'28 When satisfactory autogenous 
vein was unavailable, composite PTFE grafts were 
next preferentially used for infrageniculate bypass 
procedures .27 ,  28
No difference in limb salvage or graft patency 
rates was observed after early failure of femoropopli- 
teal compared with femorotibial/femoropedal by- 
pass grafts. Although unexpected, this probably was 
because of our preferential use of autogenous vein, 
whenever possible, for infrapopliteal bypass grafts. In 
addition, 80% of the femoropopliteal bypass grafts 
wcre to the infrageniculate popliteal artery. Several 
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Table IV. Comparison of risk factors between patients anticoagulated versus not anticoagulated after 
index bypass and primary versus repeat leg bypass procedures 
Anticoagulation after index procedure Index procedure 
Risk factor No Tes S{#nificance PHmary Repeat Significance 
No. 66 37 64 48 
Age (yr) 66 -+ 11 64 -+ 12 NS 66 -+ 12 64 -+ 10 NS 
Male 67% 57% NS 59% 71% NS 
Female 33% 43% 41% 29% 
Diabetes 35% 30% NS 41% 23% p < 0.05 
Smoldng 62% 70% NS 59% 75% p < 0.10 
Hypertension 55% 65% NS 52% 71% p < 0.05 
Hyperlipidemia 23% 19% NS 17% 25% NS 
Cardiac disease 36% 62% p < 0.01 34% 54% p < 0.05 
Renal disease 11% 8% NS 8% 10% NS 
Pulmonary disease 20% 27% NS 25% 23% NS 
Previous inflow procedure 33% 35% NS 19% 50% p < 0.001 
Femoral-dbial/pedal 65% 68% NS 53% 78% p < 0.01 
Femoral-popliteral 35% 32% 47% 22% 
PTFE graft* 21% 41% p < 0.05 18% 41% p < 0.01 
Autogenous veinJ" 77% 51% 81% 52% 
Threatened limb 79% 86% NS 80% 83% NS 
Claudication 21% 14% 20% 17% 
Repeat leg bypass 32% 65% p < 0.005 - -  - -  
Anticoagulatäon after index bypass - -  - -  28% 60% p < 0.001 
*Includes composite PTFE grafts. 
{Does not total 100% because of  small percentage of  homografts. 
studies have also shown no difference in outcome 
between bypass grafting to the popliteal or infrapop- 
liteal artery with autogenous vein for both primary 26 
or repeat leg bypass procedures) °,12 
After late graft failures, reconstruction with new 
autogenous vein grafts has resulted in the best pa- 
tency and limb salvage rates, sq°,12a~,17 Less success- 
ful results have been observed with thrombectomy, n 
thrombolysis, 29,a° or revision of the thrombosed 
graft. 9 In this series, grafts that were thrombecto- 
mized and revised or replaced at the takeback proce- 
dure had significantly better patency rates than those 
that had thrombectomy alone. Revised or replaced 
grafts also had a better limb salvage rate, although 
statistical significance was not achieved. These results 
suggest that every attempt should be made to iden- 
tify and revise any correctable problem and ifneeded, 
to completely replace the graft at the time of the 
takeback procedure. It also suggests that ifthere is no 
potential for revision, subsequent attempts at revas- 
cularization for early failure should not be per- 
formed. Ideally, the decision to not pursue any fur- 
ther revascularization attempts should be made 
before the occurrence of any early thrombotic event. 
Because only 13% of patients underwent complete 
graft replacement, no definitive conclusions can be 
drawn on whether this is superior to revision. 
Despite at least wo major lower extremity revas- 
Table V. Morbidity and mortality data after 
takeback procedure for early graft 
failure (n = 103) 
Complication No. % 
Total patients 52 51 
Death 1 1 
Wound infection 41 40 
Significant hematoma* 21 20 
Urinary tract infection 9 9 
Graft infection 6 6 
Pneumonia 4 4 
Myocardial infarction 3 3 
Respiratory failure 3 3 
Calf deep venous thrombosis 2 2 
Gastrointestinal bleed 2 2 
Transient acute renal failure 2 2 
Line sepsis 2 2 
Femoral nerve palsy 1 1 
Small bowel obstruction 1 1 
*Required operative drainage. 
cularization procedures performed, with the tal~e- 
back performed emergently and usually within 24 
hours (Fig. 1), there was a very low perioperative 
mortality rate (< 1%) seen in this series. The morbid- 
ity rate, however, especially wound-related complica- 
tions, was substantial (Table V). This was not unex- 
pected given the multiple reoperations performed on 
the same limb and the use of anticoagulation medi- 
JOURNAL OF VASCULAR SURGERY 
436 Robinson et al. September 1997 
cation in all patients after the takeback procedure. 
Significant wound hematomas that required opera- 
tive drainage and wound infections developed in 20% 
and 40% of the cases, respectively. Graft infection 
occurred in 6% of the takeback procedures and in all 
instances was preceded by a wound infection. 
Despite the somber esults, performing one take- 
back procedure still appears warranted in all patients, 
given the low mortality rate along with the inevitable 
amputation for threatened limbs when no further 
attempt at revascularization was performed. The 
limb salvage rate obtained at 1 month was signifi- 
cantly better for all takebacks (74%) and even pa- 
tients who took anticoagulation medication after a 
repeat leg bypass (in&x) procedure (57%), com- 
pared with cases that were not taken back for revas- 
cularization (12%). The considerable morbidity rate 
and extremely poor results seen with multiple take- 
backs (33% 1-month limb salvage rate), however, 
would suggest hat more than one takeback should 
not be performed. 
CONCLUSION 
Long-term limb salvage and graft patency rates 
after takeback revascularization procedures per- 
formed for early graft failure are poor and associated 
with substantial morbidity. Despite the poor out- 
come, a single takeback appears warranted in all pa- 
tients, given the low mortality rate and even more 
dismal results if no further revascularization is at- 
tempted. Multiple takebacks, however, do not ap- 
pear to be warranted, especially in patients who were 
given anticoagulation medication after the index by- 
pass procedure, in repeat leg bypass procedures, or in 
patients with no further potential for graft revision. 
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D ISCUSSION 
Dr. Dennis F. Bandyk (Tampa, Fla.). Most vascular 
surgeons have had patients with early graft thrombosis, but 
few of us have a clear recollection or knowledge of the 
follow-up of these patients, and the Norfolk group is to be 
congratulated for providing this to ns. The mechanisms of 
early graft thrombosis involve multiple anatomic and he- 
modynamic factors but have in common a development of
a low-flow stare that precedes the occlusive process. Dr. 
Robinson and his colleagues have described in detail pa- 
tient clinical factors associated with early graft failure 
gleaned from a 10-year etrospective r view. One hundred 
twelve graft failures were analyzed, accounting for 7% of all 
the bypass procedures performed. All but nine patients 
underwent attempts at graft salvage and after this takeback 
surgery, 39 grafts rethrombosed and the second half un- 
derwent another procedure. Thirty-five grafts could not be 
salvaged and 22 amputations occurred, resulting in a limb 
salvage rate of 78% at 30 days. Despite successful restora- 
tion of graft patency, which included graft replacement, 
the patency rate of these conduits was poor. Fewer than 
one half were patent at 3 months, and by 1 year the 
secondary patency rate was only 30%. What the authors did 
not teil us is why these grafts failed. Using intraoperative 
scanning , I have found that abnormal graft hemodynamics 
with low flow are the most common mechanism of early 
failure, followed closely in prevalence by the formation of 
platelet thrombus at various artery or vein segments. 
My first question to the authors concerns intraopera- 
tive assessment. Was there a routine intraoperative proto- 
col in place, and what were the findings in this group of 
patients? When grafts with low blood flow fall, even when 
systemic heparin is continued after the operation, throm- 
bectomy alone is likely to fall. A procedure that increases 
blood flow must be performed, such as creating an arterio- 
venous fistula or sequential bypass grafting. Were any such 
secondary procedures performed uring the first or second 
take-back operations? The authors uggested in their arti- 
cle that reexploration of a failed bypass graft may not be 
indicated but provide no guidelines for this decision. Un- 
less detailed hemodynamic or imaging studies are per- 
formed during these procedures and indicate a hopeless 
situation, I believe all patients wl:o are medically fit should 
return to the operating room in the setting of acute graft 
thrombosis. When intraoperative studies uggest adeqnate 
outflow, then by and large these procedures are successful. 
In our experience, the patency rate has been about 60% in 
these grafts beyond ó months. I would appreciate the 
authors' thoughts on when a vascular surgeon should 
"throw in the towel." What findings should be present on 
noninvasive testing or arteriograms? 
Dr. Kevin D. Robinson. Thank you, Dr. Bandyk, for 
those comments. Intraoperative assessment was used in 
almost all the patients here. We did not look back at our 
1600 patients to compare the early failure group versus 
patients whose graft did not fail at 30 days to compare any 
difference in their intraoperative findings. Probably 20% of 
patients did have low flow, less than 40 cm/sec on their 
intraoperative duplex scan, but that is a small number, 
about 28% of the patients, because we only started looking 
at it in 1991. As far as examining for runoffwith intraoper- 
ative angiography, there was not any association that we 
could find with what was defined on angiography as poten- 
tially a problem at the takeback, which was not thought o 
be a problem at the initial bypass procedure and what was 
called poor runoff at the time of their next takeback, did 
not really correlate with their angiographic findings. As rar 
as arteriovenous fistulas, there were several arteriovenous 
fistulas placed. None of them were at the initial procedure, 
and I cannot break that down for you and teil you exactly 
how they did compared with everybody else. The majority 
of these bypass grafts were to very distal arteries o that 
sequential procedures probably viere not an option most of 
the time. As rar as who to choose to attempt a takeback 
procedure, I don't think this really answered our question 
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as rar as saying ifyou have this, this, and this, I wouldn't 
takeback. I think the most striking finding for me was the 
association of the heparin. I don't think it was the heparin 
itself but the surgical judgement that these patients were 
very high risk and if their graft subsequently failed despite 
bringing all the tricks out of the bag, they had a signifi- 
cantly worse outcome than anybody else. I think surgical 
judgement isprobably the most important thing. I think as 
rar as deciding who not to takeback, I think that needs to 
be decided prospectively at the time of the initial opera- 
tion. I fyou didn't think about it at the initial operation, I 
think you are committed to taking them back. If you are 
doing the so-called Haft Mary bypass and you say I have 
done everything I can and I am not going to take them 
back if it falls, and it fails, I think you are justified in not 
taking them back. 
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